Dianthus Therapeutics Inc Revenue per Employee (DNTH), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Dianthus Therapeutics Inc   (NASDAQ: DNTH)
 

Dianthus Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 205.56% in the third quarter 2026, year on year to cumulative value of $2 million, Dianthus Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 24,511, this is below the company average.
Within the Healthcare sector Employees of 585 other companies have achieved higher revenue per employee. While Dianthus Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 3886 to 4005. Dianthus Therapeutics Inc has 92 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DNTH Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 205.56 % 294.3 % - -78.58 % -81.77 %
Sales per Employee (TTM) $ 24,511 15,663 9,489 22,130 33,457
DNTH's Total Ranking # 4005 # 3886 # 2360 # 2106 #
Seq. Revenue Change 59 % - - -28.28 % 105.18 %

DNTH Company Profile >> Back to DNTH Efficiency Comparisons >> Compare DNTH Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 216
Healthcare Sector # 586
Overall Market # 4005

Revenue per Employee Statistics
High Average Low
$ 74,033 $ 54,505 $ 22,130
(Sep 30 2024)   (Dec 31 2025)



Financial Statements
Dianthus Therapeutics Inc 's Revenue MRQ $ 1 Millions Visit DNTH's Income Statement
Dianthus Therapeutics Inc 's Revenues TTM $ 2 Millions Visit DNTH's aggregate revenue growth
What are DNTH's Sales? Visit DNTH's Sales by Segment




Other Ratios
Dianthus Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
DNTH's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for DNTH's Competitors
Revenue per Employee for DNTH's Suppliers
Revenue per Employee for DNTH's Customers

You may also want to know
DNTH's Sales Growth Rates DNTH's Pe Price to earnings ratio DNTH's Receivables Turnover Ratio DNTH's Stock Quote
DNTH's Net Income Growth Rates DNTH's Ps Price to Sales ratio DNTH's Sales per Employee DNTH's Asset Turnover Ratio
DNTH's Net Margin DNTH's Pb Price to Book ratio DNTH's Financial Strength Ratios DNTH's Dividend Payout Ratio
Date modified: 2026-11-06T13:02:27+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Dbv Technologies S a   22,611.76 $ 3.844  Million 170 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.